Incidence of diabetes and serum adipokines in Catalonian men. The ADIPOCAT study

References

• James PT, Rigby N, Leach R; International Obesity Task Force. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil. 2004;11:3–8.
   PubMed Web of Science ®Google Scholar
• Molarius A, Seidell J C, Sans S, Tuomilehto J, Kuulasmaa K; WHO MONICA Project. Varying sensitivity of waist action levels to identify subjects with overweight or obesity in 19 populations of the WHO MONICA Project. J Clin Epidemiol. 1999;52:1213–24.
   PubMed Web of Science ®Google Scholar
• Silventoinen K, Sans S, Tolonen H, Monterde D, Kuulasmaa K, Kesteloot H, . Trends in obesity and energy supply: an ecological analysis from the WHO-MONICA Project. Int J Obesity. 2004;28:710–8.
   PubMed Web of Science ®Google Scholar
• Castell C, Treserras R, Serra J, Goday A, Lloveras G, Salleras L. Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. Diabetes Res Clin Pract. 1999;43:33–40.
   PubMed Web of Science ®Google Scholar
• Masiá R, Sala J, Rohlfs I, Piulats R, Manresa JM, Marrugat J. Prevalencia de diabetes mellitus en la provincia de Girona, España: el estudioREGICOR. Rev Esp Cardiol. 2004;57:261–4.
   PubMedGoogle Scholar
• Valdés S, Botas P, Delgado E, Alvarez F, Díaz Cárdena F. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care. 2007;30:2258–63.
   PubMed Web of Science ®Google Scholar
• Soriguer F, Rojo-Martinez G, Almaraz MC, Esteva I, Ruiz de Adana MS, Morcillo S, . Incidence of type 2 diabetes in Southern Spain (Pizarra study). Eur J Clin Investig. 2008;38:126–33.
   PubMed Web of Science ®Google Scholar
• Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, . Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002;360:57–8.
   PubMed Web of Science ®Google Scholar
• Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26:439–51.
   PubMed Web of Science ®Google Scholar
• Schmidt MI, Duncan B, Vigo A, Pankow JS,Couper D, Ballantyne CM, . Leptin and incident type 2 diabetes: risk or protection? Diabetologia. 2006;49:2086–96.
   PubMed Web of Science ®Google Scholar
• Soderberg S, Zimmet P, Tuomilehto J, Chitson P, Gareboo H, Alberti KGMM, . Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int J Obes. 2007;31: 1126–33.
   PubMed Web of Science ®Google Scholar
• Rodés A, Sans S, Balañà LL, Paluzie G, Aguilera R, Balaguer-Vintró I. Recruitment methods and differences in early, late and nonrespondents in the first MONICA-Catalonia population survey. Rev Epidemiol Santé Publique. 1990;38:447–54.
   PubMed Web of Science ®Google Scholar
• Sans S, Paluzie G,Balañá L, Puig T, Balaguer-Vintró I. Trends in prevalence, awareness, treatment and control of arterial hypertension between 1986 and 1996: the MONICA-Catalonia study. Med Clin (Barc). 2001;117:246–53. Erratum in Med Clin (Barc). 2001;117:731.
   PubMed Web of Science ®Google Scholar
• World Health Organization MONICA Manual, version 1.1., CVD/MNC. Geneva: World Health Organization; 1986.
   Google Scholar
• US Department of Health and Human Services. Public Health Service. National Center for Health Statistics Data collection forms of the Hispanic NHANES. Hyattsville, Maryland: US Department Printing Office; 1983.
   Google Scholar
• World Health Organization/International Diabetes Federation Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: Report of a WHO/IDF consultation. Geneva: World Health Organization; 2006.
   Google Scholar
• Li S, Shin HJ, Ding E, van Dam RM. Adiponectin levels and risk of type 2 diabetes. A systematic review and meta-analysis. JAMA. 2009;302: 179–88.
   PubMed Web of Science ®Google Scholar
• Wanamatee SG, Lowe GD, Rumley A, Cherry L, Whincup PH, Sattar N. Adipokines and risk of type 2 diabetes in older men. Diabetes Care. 2007;30:1200–5.
   PubMed Web of Science ®Google Scholar
• Snijder MB, Heine RJ, Seidell J, Bouder LM, Stehouwer CDA, Neipels G, . Associations with adiponectin level with impaired glucose metabolism and type 2 diabetes in older men and women. The Hoorn Study. Diabetes Care. 2006;29:2498–503.
   PubMed Web of Science ®Google Scholar
• Brancati FL, Kao WH, Folsom A, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and white adults. The Atherosclerosis RIsk in Communities study. JAMA. 2000;283:2253–9.
   PubMed Web of Science ®Google Scholar
• Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelson J, Hegele RA, . Adipokines and incident type 2 diabetes in an aboriginal Canadian population. Diabetes Care. 2008;31:1410–5.
   PubMed Web of Science ®Google Scholar
• Dullaart RPF, deVries R, vanTol A, Sluiter WJ. Lower plasma adiponectin is a marker of increased intima-media thickness associated with type-2 diabetes mellitus and with male gender. Eur J Endocrinol. 2007;156:387–94.
   PubMed Web of Science ®Google Scholar
• Wang J, Li H, Franco OH, Yu Z, Liu Y, Lin X. Adiponectin and metabolic syndrome in middle-age and elderly Chinese. Obesity. 2008;16:172–8.
   PubMedGoogle Scholar
• Salas-Salvado J, Granada M, Bullo M, Corominas A, Casas P, Foz M. Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome. Metabolism. 2007;56:1486–92.
   PubMed Web of Science ®Google Scholar
• Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, . Adiponectin and the development of type 2 diabetes: the Atherosclerosis RIsk in Communities study. Diabetes. 2004;53: 2473–8.
   PubMed Web of Science ®Google Scholar
• Hivert MH, Sullivan LM, Shrader P, Fox CS, Nathan DM, D’Agostino R, . Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study. Diabetologia. 2011;54: 1019–24.
   PubMed Web of Science ®Google Scholar
• Berg AH, Du Combs TPX, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7:947–53.
   PubMed Web of Science ®Google Scholar
• Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein ACRP30. J Clin Invest. 2001;108:1875–81.
   PubMed Web of Science ®Google Scholar
• Sun J, Xu J, Dai Z, Sun Y. Intermittent high glucose stimulate MCP-1, IL-18 and PAI-1, but inhibit adiponectin expression and secretion in adipocytes dependent of ROS. Cell Biochem Biophys. 2009;55: 173–80.
   PubMed Web of Science ®Google Scholar
• Ozeki H, Hara K, Yatsuka C, Nakano T, Matsumoto S, Suetsugu M, . Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus. Metabolism. 2009;58:1470–6.
   PubMed Web of Science ®Google Scholar
• Duncan BB, Schmidt MI, Pankow JS, Ballantyne C, Couper D, Vigo A, . Low-grade systemic inflammation and the development of type 2 diabetes. The Atherosclerosis Risk in Communities Study. Diabetes. 2003;52:1799–805.
   PubMed Web of Science ®Google Scholar
• Koenig W, Khuseyinova N, Baumer J, Meisinger C, Löwel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle aged men. Results from the 18-year follow-up of a large cohort from Southern Germany. JAm CollCardiol. 2006;48:1369–77.
   PubMed Web of Science ®Google Scholar
• Krakoff J, Funahashi T, Stehouwer CDA, Schalkwijk CJ, Tanaka S, Matsuzawa Y, . Inflammatory markers, adiponectin and risk of type 2 diabetes in the Pima Indian. Diabetes Care. 2003;26:1745–51.
   PubMed Web of Science ®Google Scholar
• Vázquez G, Duval S, Jacobs D, Silventoinen K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Am J Epidemiol. 2007;29:115–28.
   Google Scholar